Skip to main content

Table 3 A multivariate analysis of a likelihood of a positive test for COVID-19

From: Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective

  COVID − 19 (+) Difference (95% CI)
ACEIs or ARBs 1.01 (0.89–1.13) 0.9345
61–69 1.36 (1.2–1.53) <.0001
70–79 1.03 (0.91–1.18) 0.3633
≥80 0.7 (0.6–0.8) <.0001
Female 1.33 (1.21–1.46) <.0001
Diabetes mellitus 0.92 (0.84–1.01) 0.0739
Cardiovascular disease 0.89 (0.73–1.09) 0.2599
Cerebrovascular disease 0.76 (0.67–0.87) <.0001
Ischemic heart disease 0.65 (0.55–0.75) <.0001
COPD 0.43 (0.32–0.58) <.0001
Malignancy 0.31 (0.26–0.37) <.0001
Renal replacement therapy 0.19 (0.13–0.29) <.0001
  1. * P < .05; ** P < .01; *** P < .001
\